A randomized trial of sertraline as a cessation aid for smokers with a history of major depression

American Journal of Psychiatry

Volumn 159, Issue 10, 2002, Pages 1731-1737

  Covey, Lirio S ^a   Glassman, Alexander H ^a   Stetner, Fay ^a   Rivelli, Sarah ^a   Stage, Kurt ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BUSPIRONE; CLONIDINE; DOXEPIN; FLUOXETINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NICOTINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; AGITATION; ANAMNESIS; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; FOLLOW UP; GENDER; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SCORING SYSTEM; SIDE EFFECT; SMOKING; SMOKING CESSATION; SYMPTOMATOLOGY; TOBACCO DEPENDENCE; TREATMENT OUTCOME; VERTIGO; WITHDRAWAL SYNDROME;

ADULT; BEHAVIOR, ADDICTIVE; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 0036788327     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.10.1731     Document Type: Article

References (37)

1. Covey LS, Glassman AH, Stetner F: Cigarette smoking and major depression. J Addict Disord 1998; 17:35-46
2. McQueen G, Born L, Steiner M: The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders. CNS Drug Rev 2001; 7:1-24
3. Blondal T, Gudmundsson LJ, Tomasson K, Jonsdottir D, Hilmarsdottir H, Kristjansson F, Nilsson F, Bjornsdottir US: The effects of fluoxetine combined with nicotine inhalers in smoking cessation - a randomized trial. Addiction 1999; 94:1007-1015
4. Hitsman B, Pingitore R, Spring B, Mahableshwarkar A, Mizes JS, Segraves KA, Kristeller JL, Xu W: Antidepressant pharmacotherapy helps some cigarette smokers more than others. J Consult Clin Psychol 1999; 67:547-554
5. Covey LS, Hughes D, Glassman AH, Blazer D, George LK: Ever smoking, quitting, and psychiatric disorders: evidence from the Durham Epidemiological Catchment Area. Tob Control 1994; 3:222-227
6. Glassman AH, Covey LS, Dalack GW, Stetner F, Rivelli SK, Fleiss J, Cooper TB: Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 1993; 54:670-679
7. Covey LS: A psychotherapeutic approach for smoking cessation counseling, in Helping the Hard-Core Smoker: A Clinician's Guide. Edited by Seidman DF, Covey LS, Mahwah, NJ, Lawrence Erlbaum Associates, 1999, pp 175-193
8. Covey LS, Glassman AH, Stetner F: Depression and depressive symptoms in smoking cessation. Compr Psychiatry 1990; 31: 350-354
9. Breslau N, Kilbey MM, Andreski P: Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry 1994; 149:464-469
10. Hughes JR: Tobacco withdrawal in self-quitters. J Consult Clin Psychol 1992; 60:689-697
11. Spitzer RL, Williams JBW, Gibbon M, First MB: Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1988
12. Fagerstrom KO: Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978; 3:235-241
13. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571
14. Radloff LS: The CES-D Scale: a self-report depression scale for research in the general population. J Applied Psychol Measurement 1977; 1:385-401
15. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
16. Glassman AH, Stetner FS, Walsh BT, Raizman P, Cooper T, Covey LS: Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA 1988; 259:2863-2866
17. Leshner Al: Addiction is a brain disease, and it matters. Science 1997; 279:45-47
18. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL: Depression and the dynamics of smoking: a national perspective. JAMA 1990; 262:1541-1545
19. Covey LS, Glassman AH, Stetner F: Depression and depressive symptoms in smoking cessation. Compr Psychiatry 1990; 31: 350-354
20. Hurt RD, Sachs DL, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM: A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337:1195-1202
21. Jorenby DE, Leischow SJ, Nides MA, Rennard SJ, Johnston JA, Hughes AR: A controlled trial of sustained release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340:685-691
22. Hall SM, Reus VI, Muñoz RF, Sees KL, Humfleet G, Hartz DT, Frederick S, Triffleman E: Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998; 55:683-690
23. Edwards NB, Simmons RC, Rosenthal TL, Hoon PW, Downs JM: Doxepin in the treatment of nicotine withdrawal. Psychosomatics 1988; 29:203-206
24. Berlin I, Said S, Spreux-Varoquaux O, Launay JM, Olivares R, Millet V, Lecrubier Y, Puech AJ: A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clin Pharmacol Ther 1995; 58:444-452
25. Glassman AH, Covey LS, Stetner F, Rivelli S: Smoking cessation and the course of major depression: a follow-up study. Lancet 2001; 357:1929-1932
26. Tsoh JY, Humfleet GL, Muñoz RF, Reus VI, Hartz DT, Hall SM: Development of major depression after treatment for smoking cessation. Am J Psychiatry 2000; 157:368-374; correction, 157:1359
27. Covey LS, Glassman AH, Stetner F: Major depression following smoking cessation. Am J Psychiatry 1997; 154:263-265
28. Quitkin FM, McGrath PJ, Rabkin JG, Stewart JW, Harrison W, Ross DC, Tricamo E, Fleiss J, Markowitz J, Klein DF: Different types of placebo response in patients receiving antidepressants. Am J Psychiatry 1991; 148:197-203
29. Paykel ES: Psychotherapy, medication combinations, and compliance. J Clin Psychiatry 1995; 56(suppl 1):24-30
30. Patten CA, Martin JE, Myers MG, Calfas KJ, Williams CD: Effectiveness of cognitive-behavioral therapy for smokers with histories of alcohol dependence and depression. J Stud Alcohol 1998; 59:327-335
31. Brown RA, Kahler CW, Niaura R, Abrams DB, Sales SD, Ramsey SE, Goldstein MG, Burgess ES, Miller IW: Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol 2001; 69:471-480
32. Abelin T, Buehler A, Muller P, Vesanen K, Imhof PR: Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet 1989; 1:7-10
33. Fiore MC, Kenford SL, Jorenby DE, Wetter DW, Smith SS, Baker TB: Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest 1994; 105: 524-533
34. Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwaltney CJ, Paty JA, Gnys M, Evoniuk G, DeVeaugh-Geiss J: The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology (Berl) 2000; 148:33-40
35. Robinson MD, Pettice YL, Smith WA, Cederstrom EA, Sutherland DE: Buspirone effect on tobacco withdrawal symptoms: a randomized placebo controlled trial. J Am Board Fam Pract 1992; 5:1-9
36. Killen JD, Fortmann SP, Schatzberg AF, Hayward C, Sussman L, Rothman M, Strausberg L, Varady A: Nicotine patch and paroxetine for smoking cessation. J Consult Clin Psychol 2000; 68: 883-889
37. Hughes JR: Why does smoking so often produce dependence? a somewhat different view. Tob Control 2001; 10:62-64